Pseudorabies / Aujeszky's Disease

Pseudorabies, also known as Aujeszky's disease, is a highly contagious viral disease of swine caused by Suid herpesvirus 1 (SuHV-1), a member of the family Herpesviridae. Despite its name, pseudorabies is not related to the rabies virus; the term arose from the similarity of neurological signs observed in affected animals. This disease has profound implications for swine production, causing respiratory illness and high mortality in young pigs, reproductive failure in breeding stock, and neurological disease across all age groups. Pseudorabies is classified as a reportable or notifiable disease in most countries due to its economic significance and potential for rapid spread.

The disease affects swine populations globally, though successful eradication programs have eliminated domestic disease from several countries including the United States, Canada, and most of the European Union. The United States declared commercial swine herds free of pseudorabies in 2004 following an intensive multi-decade eradication effort. However, the virus persists in feral swine populations, creating an ongoing risk of reintroduction to domestic herds in areas where wild pigs are present. Countries that have achieved eradication maintain strict surveillance and movement control measures to preserve their disease-free status.

The economic impact of pseudorabies on affected swine operations can be devastating. Outbreaks in naive herds cause high mortality in young pigs, often exceeding 50% in piglets under two weeks of age. Reproductive losses including abortion, stillbirth, mummified fetuses, and infertility significantly reduce breeding herd productivity. Growing pigs experience respiratory disease and reduced growth rates, extending time to market weight. Beyond direct production losses, pseudorabies-positive status restricts animal movement and trade opportunities, creating additional economic burden for affected producers.

Understanding pseudorabies remains critically important despite eradication success in many regions. The persistence of virus in feral swine populations, potential for introduction through illegal animal movements, and endemic status in some countries maintain the threat of reemergence. Swift recognition and reporting of suspected cases is essential for preventing establishment of new outbreaks. Veterinarians and producers must maintain awareness of clinical signs and reporting requirements to protect hard-won disease-free status and enable rapid response should introductions occur.

Pseudorabies is caused by Suid herpesvirus 1 (SuHV-1), a double-stranded DNA virus belonging to the subfamily Alphaherpesvirinae within the family Herpesviridae. Like other alphaherpesviruses, SuHV-1 establishes latent infections in nervous tissue, allowing infected animals to harbor the virus for life and potentially reactivate and shed virus during periods of stress. The virus demonstrates remarkable stability in the environment, remaining infectious for extended periods under favorable conditions, which contributes to its ability to spread between and within swine populations.

Transmission of pseudorabies virus occurs primarily through direct contact between infected and susceptible pigs, with the virus shed in nasal and oral secretions, and in reproductive fluids. Infected pigs can begin shedding virus before showing clinical signs, facilitating spread before disease is recognized. Aerosol transmission can occur over short distances, particularly in confined housing where infected and susceptible animals share airspace. Fomite transmission through contaminated equipment, vehicles, and clothing represents an important route of spread between farms, emphasizing the importance of biosecurity measures.

Vertical transmission from infected sows to fetuses causes the reproductive manifestations of pseudorabies. The virus crosses the placental barrier and infects developing fetuses, causing fetal death at various stages of gestation. Depending on the timing of infection, outcomes range from early embryonic death and return to estrus, to abortion of recognizable fetuses, to stillbirth and birth of weak, infected piglets. Infected boars shed virus in semen, making natural mating and artificial insemination potential routes of reproductive transmission. Colostral and milk transmission can infect nursing piglets from shedding sows.

Risk factors for pseudorabies introduction and spread include proximity to feral swine populations, inadequate biosecurity, and animal movement patterns. Feral swine represent the primary reservoir of pseudorabies virus in countries that have eradicated domestic disease, and contact between domestic pigs and wild populations poses significant risk. Operations with poor perimeter fencing, shared equipment with other farms, or inadequate quarantine protocols for incoming animals face elevated introduction risk. Stress factors including transportation, mixing of unfamiliar animals, and concurrent disease can trigger viral reactivation in latently infected carriers, leading to shedding and transmission.

The pathophysiology of pseudorabies involves initial viral replication in the upper respiratory tract following oronasal exposure, with subsequent spread to regional lymph nodes and viremic dissemination throughout the body. The virus demonstrates strong neurotropism, migrating along peripheral nerves to reach the central nervous system where it causes the characteristic neurological signs. In pregnant animals, viremic spread leads to placental and fetal infection. Following primary infection, the virus establishes latency in trigeminal ganglia and other neural tissue, persisting indefinitely and maintaining the potential for reactivation and renewed shedding throughout the animal's life.

Early warning signs of pseudorabies in swine populations may initially mimic other common respiratory diseases, potentially delaying recognition of this serious condition. Affected pigs may display elevated body temperature, reduced feed intake, and mild respiratory signs including sneezing and nasal discharge. Lethargy and depression are common early findings, with affected animals often separating from herd mates and showing reduced activity. In breeding herds, initial signs may include decreased conception rates and increased returns to estrus before reproductive failure becomes apparent.

Symptoms vary dramatically by age, with young piglets showing the most severe disease and highest mortality rates. Piglets infected during the first two weeks of life develop severe neurological disease characterized by trembling, incoordination, paddling movements, convulsions, and paralysis. Affected piglets may adopt a characteristic dog-sitting posture and display opisthotonos (severe arching of the back). Mortality in this age group frequently exceeds 50% and can approach 100% in severely affected litters. Piglets may die within 24 to 48 hours of showing initial signs, making early intervention impossible.

Behavioral changes in older growing pigs and adult swine with pseudorabies include lethargy, anorexia, and altered social behavior. Animals may appear dull and unresponsive or conversely may show nervousness and hypersensitivity to stimuli. Reproductive females often display decreased interest in breeding, and boars may show reduced libido. In some cases, pigs demonstrate the intense pruritus (itching) that gives the disease its alternate name "mad itch," though this sign is more commonly observed in cattle and other non-porcine species affected by the virus.

Physical signs in growing and adult swine typically involve the respiratory and nervous systems. Respiratory manifestations include coughing, sneezing, nasal discharge, and dyspnea (labored breathing) that may progress to severe pneumonia. Fever ranging from 40°C to 42°C (104°F to 108°F) accompanies acute infection. Neurological signs in older pigs are generally less severe than in neonates but may include ataxia, circling, head tilt, and muscle tremors. Vomiting and profuse salivation may occur. Adult pigs typically survive infection but remain latently infected and capable of viral reactivation and shedding.

Symptom progression in pseudorabies outbreaks follows predictable patterns based on age distribution and immune status of affected populations. In naive herds experiencing initial introduction, disease often appears first in young pigs or breeding stock depending on the introduction route. Rapid spread through the susceptible population leads to escalating clinical cases over days to weeks. Mortality is concentrated in the youngest animals, while respiratory disease predominates in growers and adults. The outbreak typically peaks 2 to 4 weeks after introduction and gradually subsides as herd immunity develops, though latent infection persists.

Emergency symptoms requiring immediate veterinary attention and disease investigation include any clustering of neurological signs in young pigs, particularly tremors, convulsions, and high mortality in piglets. Sudden increases in abortion rates, stillbirth, or mummified fetuses warrant urgent diagnostic workup. Respiratory disease outbreaks with concurrent neurological signs are highly suggestive of pseudorabies. Given the reportable disease status, any suspected pseudorabies case must be reported to appropriate regulatory authorities immediately. Delay in reporting can result in regulatory penalties and impedes disease control efforts.

Clinical diagnosis of pseudorabies requires careful assessment of clinical signs, age-specific disease patterns, and epidemiological factors. Veterinarians evaluating suspect cases should note the combination of neurological, respiratory, and reproductive signs, with particular attention to the severe neurological disease and high mortality in young piglets that characterizes this condition. History of potential exposure to feral swine or contact with animals of unknown disease status increases clinical suspicion. The presence of intense pruritus in affected cattle, dogs, or other species on the same premises strongly suggests pseudorabies.

Laboratory diagnosis confirms pseudorabies infection and is essential given the regulatory implications of positive findings. Virus isolation from tissues or secretions provides definitive diagnosis, with tonsil, brain, and lung tissue preferred for isolation attempts from dead animals. Polymerase chain reaction (PCR) testing offers rapid, sensitive detection of viral DNA in clinical samples including nasal swabs, tonsil tissue, and brain. PCR can be performed on pooled samples for herd-level surveillance. Immunofluorescence or immunohistochemistry on tissue sections can demonstrate viral antigen in affected organs, particularly brain tissue from animals with neurological signs.

Serological testing detects antibodies against pseudorabies virus and plays a central role in surveillance and eradication programs. Enzyme-linked immunosorbent assay (ELISA) tests can screen large numbers of samples efficiently, with confirmatory testing performed on positive samples. Differential ELISA tests can distinguish antibodies induced by gene-deleted marker vaccines from those resulting from field virus infection, enabling effective surveillance in vaccinated populations. Serial testing at appropriate intervals is used to monitor herd status and detect new infections.

Differential diagnosis for pseudorabies includes other causes of neurological disease in pigs such as streptococcal meningitis, salt poisoning (water deprivation), hypoglycemia, and Teschen-Talfan disease. Reproductive failure must be differentiated from porcine parvovirus, PRRS, leptospirosis, and various bacterial infections. Respiratory disease can mimic swine influenza, Mycoplasma pneumonia, and Actinobacillus pleuropneumoniae. The unique combination of age-specific neurological disease, respiratory signs, and reproductive failure helps distinguish pseudorabies from conditions affecting single body systems. All suspected pseudorabies cases should be reported to regulatory authorities for official investigation and diagnostic confirmation.

Treatment options for pseudorabies are extremely limited, as no antiviral medications effectively eliminate the virus, and the establishment of latent infection means truly affected animals cannot be cured. The primary focus of response to pseudorabies cases involves regulatory compliance, disease containment, and supportive care for affected animals while management decisions are made regarding herd disposition. Immediate consultation with state or federal veterinary authorities is mandatory upon confirmation of pseudorabies, as this is a reportable disease with significant regulatory implications.

Medical management during pseudorabies outbreaks focuses on supportive care and control of secondary infections. Affected animals showing fever and anorexia may benefit from anti-inflammatory medications to improve comfort and encourage feed intake. Broad-spectrum antibiotics are commonly administered to prevent or treat secondary bacterial pneumonia that frequently complicates viral respiratory infection. However, given the regulatory status of pseudorabies and the latent carrier state established in survivors, treatment is often not the primary focus compared to containment and eradication measures.

Supportive care for affected pigs includes maintaining appropriate environmental conditions, ensuring access to feed and water, and providing nursing care for weak animals. Young piglets showing neurological signs have extremely poor prognosis and often die despite intervention. Keeping affected animals warm, hydrated, and as comfortable as possible represents the extent of feasible supportive measures. Animals that survive acute infection will remain latently infected for life, which has important implications for herd management and regulatory compliance.

Herd management decisions following pseudorabies diagnosis depend on regulatory requirements, production system, and producer circumstances. In countries with active eradication programs, confirmed positive herds face movement restrictions, mandatory testing, and may be required to undergo depopulation. In endemic areas, vaccination combined with test-and-removal protocols may allow continued production while working toward elimination. The goal of regulatory response is typically elimination of infection from the premises and prevention of spread to other herds.

Treatment decisions must acknowledge the regulatory reality that pseudorabies-positive pigs face significant restrictions and may have limited commercial value regardless of clinical recovery. In the United States and other countries that have achieved eradication, detection of pseudorabies triggers a comprehensive regulatory response focused on determining the source of infection, preventing spread, and eliminating the virus from affected premises. Producers facing pseudorabies diagnosis should work closely with regulatory veterinarians to understand requirements and options.

Economic considerations heavily influence pseudorabies response decisions. The costs of quarantine, testing, and movement restrictions can be substantial even before considering potential depopulation requirements. Some producers may choose voluntary depopulation and repopulation with negative animals rather than attempting prolonged control and testing programs. Indemnity programs may be available in some jurisdictions to offset losses from depopulation. Working with regulatory veterinarians and industry organizations helps producers navigate the complex decisions following pseudorabies diagnosis.

Recovery from acute pseudorabies infection is possible for older growing pigs and adult swine, though prognosis for young piglets with neurological disease is extremely poor. Animals that survive acute infection typically recover clinical health within 2 to 3 weeks but remain latently infected with virus persisting in neural tissue. This latent carrier state has critical implications, as recovered animals can reactivate and shed virus during periods of stress, maintaining the potential for disease transmission indefinitely.

Post-outbreak monitoring in pseudorabies-affected herds involves intensive serological surveillance to determine infection prevalence and track disease dynamics. Regulatory authorities typically mandate testing protocols specifying sample sizes, testing intervals, and criteria for demonstrating disease freedom. Herd reproductive and production parameters should be monitored to identify ongoing impacts and guide management decisions. Detailed record keeping of test results, animal movements, and clinical observations supports both regulatory compliance and informed management.

Prognosis at the herd level depends on management response and regulatory requirements. Herds in regions with active eradication programs typically must eliminate all infected and exposed animals to regain disease-free status. This may require complete depopulation followed by thorough cleaning and disinfection before restocking with negative animals. In endemic regions where eradication is not mandated, herds may achieve stable endemic status with controlled vaccination and management, though this approach maintains ongoing risk of clinical disease and trade restrictions.

Return to production following pseudorabies depends entirely on regulatory disposition of the affected herd. Premises cleared for repopulation must meet stringent requirements for cleaning, disinfection, and downtime before introducing new animals. Restocked herds typically face extended surveillance periods with mandatory testing to demonstrate continued freedom from infection. The capital costs of depopulation and restocking, combined with lost production during downtime, represent major financial impacts that affect producer decisions and recovery timelines.

Vaccination against pseudorabies is available and has played a crucial role in eradication programs, though its use is regulated or prohibited in disease-free regions to preserve the ability to detect field virus infection. Modified-live and killed vaccines exist, with gene-deleted marker vaccines enabling serological differentiation between vaccinated and infected animals (DIVA concept). In endemic areas, vaccination reduces clinical disease and shedding, though it does not prevent infection or establishment of the latent carrier state. Vaccination protocols typically target breeding stock and may include multiple doses to achieve optimal protection.

Biosecurity measures represent the primary defense against pseudorabies introduction in disease-free herds and regions. Strict control of animal movements, including rigorous sourcing from known-negative herds and quarantine with testing of all incoming animals, prevents most introductions through purchased stock. Effective perimeter fencing to prevent contact between domestic pigs and feral swine is essential in regions where wild populations exist. Personnel entry controls, vehicle sanitation, and management of other potential fomites reduce environmental introduction risk.

Prevention of contact with feral swine is particularly critical in regions where wild populations harbor pseudorabies virus. Double-fencing systems with clear zones between fences can prevent nose-to-nose contact even when feral pigs approach facility perimeters. Hunters should not bring feral swine carcasses or tissues onto premises housing domestic pigs. Dogs used for hunting should not contact domestic swine, as they can develop fatal pseudorabies infection and potentially serve as mechanical vectors.

Surveillance and testing programs maintain awareness of pseudorabies status at herd, regional, and national levels. Slaughter surveillance programs test samples from market hogs to detect infections that may have escaped recognition. Breeding herd surveillance involves periodic testing to maintain or verify disease-free status. Trace-back investigations on positive cases identify sources of infection and potential spread. Strong surveillance systems enable rapid detection and response when pseudorabies occurs.

Quarantine and testing protocols for animal introductions must be rigorous to prevent bringing pseudorabies into negative herds. All breeding stock should originate from herds with documented negative status, preferably from pseudorabies-free regions. Incoming animals should undergo isolation quarantine of at least 30 days with serological testing before and after the isolation period. Any animals testing positive or of uncertain status should not be introduced. These protocols apply to purchased breeding stock, show animals, and any other swine entering the premises.

Daily management and monitoring in herds at risk for or recovering from pseudorabies requires heightened awareness and systematic observation. Personnel should be trained to recognize clinical signs suggestive of pseudorabies including neurological abnormalities, respiratory disease clusters, and reproductive failures. Daily health observations should be documented, with immediate escalation of any suspicious findings to management and veterinary personnel. Mortality should be tracked by age group and investigated promptly, as clustering of deaths in young pigs may indicate disease presence.

Housing and environmental management contribute to pseudorabies prevention through physical separation from infection sources and optimization of animal health. Facilities should be designed and maintained to prevent contact with feral swine, including secure perimeter fencing and building construction that excludes wildlife. All-in-all-out management by building or room reduces disease persistence and transmission between groups. Thorough cleaning and disinfection between groups eliminates environmental virus. Ventilation systems should minimize aerosol exposure risk from neighboring premises.

Herd health programs addressing pseudorabies incorporate biosecurity, surveillance, and where permitted, vaccination strategies. Biosecurity audits identify vulnerabilities in facilities and management practices requiring correction. Surveillance testing schedules maintain awareness of herd status and enable early detection of any infection. In endemic regions, vaccination programs are coordinated with test-and-removal protocols to progressively reduce infection prevalence. Veterinarians develop comprehensive health programs integrating pseudorabies prevention with management of other significant diseases.

Record keeping for pseudorabies management includes testing results, vaccination records, animal movements, and clinical observations. Regulatory compliance typically requires detailed documentation of testing programs and results. Animal identification systems enable individual tracking for testing and trace-back purposes. Production records including reproductive performance, mortality rates, and growth data help identify disease impacts and guide management decisions. Computerized systems facilitate data management and analysis for larger operations.

Economic considerations in pseudorabies management include costs of prevention measures balanced against potential losses from disease introduction. Investments in biosecurity infrastructure, testing programs, and vaccination (where applicable) must be weighed against the catastrophic costs of pseudorabies outbreaks including mortality, lost production, regulatory restrictions, and potential depopulation requirements. Operations in regions with eradication programs face particular economic stakes, as positive findings can result in total loss of herd value. Insurance and risk management strategies may provide some financial protection against these losses.

All breeds and genetic lines of domestic swine demonstrate susceptibility to pseudorabies virus infection, with no breeds showing natural resistance or immunity. The disease affects pigs of all ages and genetic backgrounds, from heritage breeds in extensive production systems to modern commercial genetics in intensive confinement operations. While breed differences in immune response may influence individual clinical outcomes, all swine are vulnerable to infection and capable of establishing the latent carrier state that perpetuates viral persistence.

Production type and management system influence exposure risk more than genetic factors. Outdoor and pasture-based operations face elevated risk of contact with feral swine compared to enclosed confinement facilities. Smaller operations with less sophisticated biosecurity may experience greater difficulty preventing introductions. Show pigs and animals participating in exhibitions face exposure risk from commingling with swine of unknown disease status. All production types must implement appropriate biosecurity measures to prevent pseudorabies introduction.

Genetic selection has not focused on pseudorabies resistance, as prevention relies primarily on biosecurity and vaccination rather than genetic approaches. In regions that have achieved eradication, any infection is addressed through elimination rather than management, removing selection pressure for resistance traits. Research has not identified significant genetic variation in pseudorabies susceptibility that would enable meaningful selection programs. Producers should focus on biosecurity and management practices rather than genetic factors when addressing pseudorabies risk.

Several conditions commonly co-occur with pseudorabies or share similar clinical presentations requiring differentiation. Porcine reproductive and respiratory syndrome (PRRS) can present concurrently with pseudorabies, particularly in operations with poor biosecurity that allows introduction of multiple pathogens. Secondary bacterial infections including streptococcal meningitis, Haemophilus parasuis, and bacterial pneumonia frequently complicate pseudorabies cases, contributing to morbidity and mortality. Mycoplasmal pneumonia may be present as an underlying condition exacerbated by viral infection.

Conditions with similar neurological presentations include streptococcal meningitis, salt poisoning (water deprivation), hypoglycemia in young piglets, and Teschen-Talfan disease (porcine enteroviral encephalomyelitis). Salt poisoning produces neurological signs including convulsions and is associated with restricted water access followed by sudden availability. Streptococcal meningitis causes neurological disease that may be confused with pseudorabies, though typically without the respiratory and reproductive components. Brain tissue examination and laboratory testing differentiate these conditions.

Complications and sequelae of pseudorabies include the establishment of latent carrier status in survivors, which has profound implications for individual animal value and herd management. Recovered animals may experience reduced growth performance and chronic respiratory compromise from lung damage sustained during acute infection. Breeding females that survive pseudorabies outbreaks may have reduced subsequent reproductive performance. The regulatory consequences of pseudorabies diagnosis, including movement restrictions and potential depopulation requirements, often exceed the direct clinical impacts of the disease itself.